This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on january 26, 2018.(b)(4).The returned sample was visually inspected upon receipt.It was found that the blood inlet port on the oxygenator was broken and missing.Additionally, there were scuff marks noted around the corner where inlet is located.A retention sample was obtained from affected product code/lot number combination.The retention was visually inspected and found to have no damages or any other anomalies, specifically on the venous (blood) inlet port.All oxygenators are 100% visually inspected multiple times in the production process.The packaging of the product also ensures protection against damage to the ports.It is likely that the port was damaged by a shock force at some point during the handling of the product; however, when or how this shock force was applied was not able to be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|